LUNG
Pulmonx Corp · Healthcare · Market cap $78.2M
Insiders sold $177K net in the last 90 days ·4 sellers, 0 buyers· latest Form 4 filed Sep 3, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$548K
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Latest filing
Sep 3, 2026
French Glendon E. III
Pulmonx Corp (LUNG) has 23 SEC Form 4 filings (66 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Sep 3, 2026.
Inside the rolling window, 5 insiders at Pulmonx Corp reported no open-market purchases and 17 open-market sales totaling $548K. The most active filer is President and CEO French Glendon E. III with 5 filings. Insiders have net sold $321K over the trailing 6 months. The most recent open-market filing is a sale of 41,882 shares by President and CEO French Glendon E. III, dated Sep 1, 2026, worth $95K.
- Industry:Medical - Devices
- CEO:Glendon E. French
- Employees:296
- HQ:Redwood City, CA, US
- IPO:2020-10-01
| Source | |||||||
|---|---|---|---|---|---|---|---|
French Glendon E. IIIFirst in 3 months | President and CEO | Sale | 41,882 | $95K | Sep 3 | -19.5% | SEC ↗ |
Radhakrishnan SrikanthFirst in 3 months | Chief Science & Techn. Officer | Sale | 14,245 | $32K | Sep 3 | -19.5% | SEC ↗ |
Lehman David AaronFirst in 3 months | General Counsel | Sale | 14,334 | $32K | Sep 3 | -19.5% | SEC ↗ |
Rose Geoffrey BeranFirst in 3 months | Chief Commercial Officer | Sale | 7,879 | $18K | Sep 3 | — | SEC ↗ |
Radhakrishnan SrikanthFirst in 3 months | Chief Science &Techn. Officer | Sale | 14,497 | $22K | Jun 3 | — | SEC ↗ |
Rose Geoffrey BeranFirst in 3 months | CHIEF COMMERCIAL OFFICER | Sale | 8,023 | $12K | Jun 3 | — | SEC ↗ |
Lehman David AaronFirst in 3 months | GENERAL COUNSEL | Sale | 14,594 | $22K | Jun 3 | — | SEC ↗ |
French Glendon E. IIIFirst in 3 months | President and CEO | Sale | 42,638 | $66K | Jun 3 | — | SEC ↗ |
French Glendon E. IIIFirst in 3 months | President and CEO | Sale | 13,511 | $21K | Jun 3 | — | SEC ↗ |
Rose Geoffrey BeranFirst in 3 months | CHIEF COMMERCIAL OFFICER | Sale | 7,732 | $11K | Mar 4 | — | SEC ↗ |
Radhakrishnan SrikanthFirst filing | Chief Science &Techn. Officer | Sale | 10,483 | $15K | Mar 4 | — | SEC ↗ |
Lehman David AaronFirst in 3 months | GENERAL COUNSEL | Sale | 12,237 | $17K | Mar 4 | — | SEC ↗ |
French Glendon E. IIIFirst in 3 months | President and CEO | Sale | 67,813 | $97K | Mar 4 | — | SEC ↗ |
Florin Daniel PFirst filing | Director | Sale | 23,321 | $46K | Dec 9 | — | SEC ↗ |
Lehman David AaronFirst filing | GENERAL COUNSEL | Sale | 10,278 | $16K | Dec 3 | — | SEC ↗ |
Rose Geoffrey BeranFirst filing | CHIEF COMMERCIAL OFFICER | Sale | 6,322 | $10K | Dec 3 | — | SEC ↗ |
French Glendon E. IIIFirst filing | President and CEO | Sale | 8,805 | $14K | Dec 3 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does LUNG have?
Pulmonx Corp (LUNG) has 23 SEC Form 4 filings (66 transaction rows) in the rolling 365-day window, disclosed by 5 distinct insiders. Most recent filing: Sep 3, 2026.
When was the most recent SEC Form 4 filing for LUNG?
The most recent Form 4 filing for LUNG on Tracefour is dated Sep 3, 2026.
Who is the most active insider at LUNG?
The most active SEC Form 4 filer at LUNG in the rolling window is President and CEO French Glendon E. III, with 5 filings.
What is the net insider flow at LUNG over the last 6 months?
Over the trailing 180 days, insiders at LUNG have net sold $321K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at LUNG in the current window?
Inside the rolling window, insiders at LUNG bought $0 and sold $548K based on SEC Form 4 filings.
Can I get alerts for LUNG insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Pulmonx Corp (LUNG). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Pulmonx Corp is in the Healthcare sector.